Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell P Levesque

Showing results (21-30 of 203) with videos related to

Pageof 21
Sort By:
Medicina (Kaunas, Lithuania)|March 28, 2026
Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in MelanomaAndrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque, et al.
The Journal of Investigative Dermatology|November 10, 2021
STK11 Prevents Invasion through Signal Transducer and Activator of Transcription 3/5 and FAK Repression in Cutaneous MelanomaAndreas Dzung, Annalisa Saltari, Natascia Tiso, et al.
Biology Open|May 3, 2018
Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cellsTobias Sinnberg, Heike Niessner, Mitchell P Levesque, et al.
The Journal of Investigative Dermatology|July 25, 2017
HLA-A*26 Is Correlated With Response to Nivolumab in Japanese Melanoma PatientsYoshihiro Ishida, Atsushi Otsuka, Hidenori Tanaka, et al.
Oncoimmunology|September 19, 2017
MEK inhibition and immune responses in advanced melanomaReinhard Dummer, Egle Ramelyte, Sabrina Schindler, et al.
Expert Opinion on Investigational Drugs|January 9, 2014
Novel therapies for cutaneous T-cell lymphoma: what does the future hold?Emmanuella Guenova, Wolfram Hoetzenecker, Sima Rozati, et al.
Foods (Basel, Switzerland)|August 27, 2021
Microgreens: Functional Food with Antiproliferative Cancer Properties Influenced by LightFrancesca Truzzi, Anne Whittaker, Chiara Roncuzzi, et al.
Science Immunology|April 1, 2022
Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapyTobias Hoch, Daniel Schulz, Nils Eling, et al.
Oncotarget|September 25, 2023
Addendum: Impact of Covid-19 on the management of patients with metastatic melanomaMichèle Welti, Phil F Cheng, Joanna Mangana, et al.
Oncotarget|December 29, 2022
Impact of Covid-19 on the management of patients with metastatic melanomaMichèle Welti, Phil F Cheng, Joanna Mangana, et al.
Pageof 21

Showing results (21-30 of 203) with videos related to

Sort By:
Pageof 21
Medicina (Kaunas, Lithuania)|March 28, 2026
Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in MelanomaAndrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque, et al.
The Journal of Investigative Dermatology|November 10, 2021
STK11 Prevents Invasion through Signal Transducer and Activator of Transcription 3/5 and FAK Repression in Cutaneous MelanomaAndreas Dzung, Annalisa Saltari, Natascia Tiso, et al.
Biology Open|May 3, 2018
Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cellsTobias Sinnberg, Heike Niessner, Mitchell P Levesque, et al.
The Journal of Investigative Dermatology|July 25, 2017
HLA-A*26 Is Correlated With Response to Nivolumab in Japanese Melanoma PatientsYoshihiro Ishida, Atsushi Otsuka, Hidenori Tanaka, et al.
Oncoimmunology|September 19, 2017
MEK inhibition and immune responses in advanced melanomaReinhard Dummer, Egle Ramelyte, Sabrina Schindler, et al.
Expert Opinion on Investigational Drugs|January 9, 2014
Novel therapies for cutaneous T-cell lymphoma: what does the future hold?Emmanuella Guenova, Wolfram Hoetzenecker, Sima Rozati, et al.
Foods (Basel, Switzerland)|August 27, 2021
Microgreens: Functional Food with Antiproliferative Cancer Properties Influenced by LightFrancesca Truzzi, Anne Whittaker, Chiara Roncuzzi, et al.
Science Immunology|April 1, 2022
Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapyTobias Hoch, Daniel Schulz, Nils Eling, et al.
Oncotarget|September 25, 2023
Addendum: Impact of Covid-19 on the management of patients with metastatic melanomaMichèle Welti, Phil F Cheng, Joanna Mangana, et al.
Oncotarget|December 29, 2022
Impact of Covid-19 on the management of patients with metastatic melanomaMichèle Welti, Phil F Cheng, Joanna Mangana, et al.
Pageof 21